3 Reasons to Buy TSMC Stock Like There's No Tomorrow

Taiwan Semiconductor Manufacturing reported robust 2025 results with full-year revenue of $122 billion, sales up 36% year-over-year and quarterly sales growth of 35% (Q1), 44% (Q2), 41% (Q3) and 26% (Q4). Management is guiding for ~30% sales growth in 2026 and a 25% CAGR through 2029, while profitability expanded in Q4 with gross margin rising to 62.3% (from 59%) and operating margin to 54% (from 49%); guidance calls for Q1 2026 gross margin of 63–64% and operating margin of 54–56%, with long-term gross margin above 56%. High-performance computing (including AI) comprised 58% of 2025 revenue and grew 48% YoY, and TSMC is boosting capex to about $54 billion in 2026 (from $41 billion in 2025) with 70–80% directed to advanced process technologies to meet surging AI/HPC demand.

Analysis

Market structure: TSMC (TSM) is the primary beneficiary—higher AI/HPC demand and a guided 25% CAGR through 2029 lift fabs, ASML (ASML) and equipment suppliers (e.g., LRCX) and hyperscalers (NVDA customers) also win; legacy IDMs (INTC) and constrained regional foundries (SMIC) are pressured as pricing power concentrates. The 2026 capex jump to ~$54B (70–80% on advanced nodes) signals tight supply through 2026–H1 2027 and strong pricing in HPC wafers, but risks a mid-cycle capacity inflection by 2028 if demand growth slows.

Risk assessment: Tail risks include a geopolitical Taiwan-China shock (high impact, low prob), a sudden hyperscaler AI capex pullback (demand shock >20% yoy), or an ASML EUV shipment delay that would delay node ramps by 6–12 months. Near term (days) expect volatility around earnings/guide updates; medium term (3–12 months) depends on capacity ramp and yield curves; long term (2026–2029) hinge on sustaining >56% gross margin and hyperscaler concentration (top customers >X% of HPC revenue).

Trade implications: Direct: consider a 2–3% portfolio long in TSM stock as core exposure; if more aggressive, buy 12–18 month LEAPS (Jan 2028) call spreads 10–20% OTM to cap spend. Pair: long TSM / short INTC (equal dollar) to express foundry vs IDM secular gap. Options hedge: buy 6–9 month puts (5–10% OTM) for downside protection if entry occurs near recent highs. Rotate +2% into SOXX from consumer cyclicals to play sector tailwinds.

Contrarian angles: Consensus underestimates execution risk—large capex raises probability of near-term yield issues and a 2027–28 oversupply downcycle that could compress gross margins below the guided 56% floor. Historical parallel: past foundry booms (post-smartphone cycles) saw rapid margin mean reversion once capacity normalized. Monitor wafer starts, TSMC utilization, ASML EUV shipping cadence, and top-customer capex plans for early signs of demand slowdown.

Key Decisions for Investors

• Establish a 2–3% long position in TSM (TSM) within 2–4 weeks; if TSM pulls back >5% from current levels, add incrementally to a 4–5% target weight. Rationale: 30% guidance for 2026 and 25% CAGR through 2029 justify core exposure, but stage sizing to manage execution risk.
• Buy a Jan 2028 TSM call spread (10–20% OTM debit spread) sized to equal a 1–2% portfolio directional bet to capture multi-year AI/HPC upside while capping premium; simultaneously sell near-term (90-day) covered calls if already long to harvest time decay.
• Open a relative-value pair: go long TSM and short INTC (equal dollar, reduce portfolio beta) to play foundry advantage vs legacy IDM structural decline; target pairs for 6–12 month horizon and trim if spread narrows by 50% or TSM outperforms by +20%.
• Hedge macro tail risk: buy 6–9 month TSM 5–10% OTM puts sized to cover 25–50% of long equity exposure if geopolitical or demand shocks emerge. Monitor ASML EUV shipment dates and top-customer capex disclosures weekly; tighten hedges if delays or capex cuts >15% are reported.
• Reallocate +2% portfolio weight into SOXX (semiconductor ETF) funded from consumer discretionary within next month to capture sector-wide capex tailwinds; exit/reduce if SOXX outperforms S&P by >20% or if TSM gross margin guidance falls below 56%.